TAK – Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company L

TAK

$14.96

Name : Takeda Pharmaceutical Company L

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $46,730,252,288.00

EPSttm : 0.23

Takeda Pharmaceutical Company L

$14.96

0.23%

$0.035

Float Short %

0.2

Margin Of Safety %

Put/Call OI Ratio

0.13

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

14.95

Target Price

17.27

Analyst Recom

2.07

Performance Q

-1.38

Relative Volume

0.78

Beta

0.26

Ticker: TAK

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-05-07	TAK	15.06	0.13	0.09	2151
2025-05-08	TAK	14.28	0.13	0.05	2240
2025-05-09	TAK	14.36	0.13	0.35	2246
2025-05-12	TAK	14.19	0.14	0.27	2250
2025-05-13	TAK	13.73	0.14	0.01	2291
2025-05-14	TAK	13.7	0.12	0.00	2437
2025-05-15	TAK	14.01	0.12	0.00	2433
2025-05-16	TAK	14.1	0.12	0.04	2437
2025-05-19	TAK	14.23	0.15	0.08	2057
2025-05-20	TAK	14.27	0.15	0.08	2063
2025-05-21	TAK	14.31	0.15	0.00	2074
2025-05-22	TAK	14.43	0.15	0.00	2076
2025-05-23	TAK	14.56	0.14	0.00	2105
2025-05-27	TAK	14.69	0.14	0.02	2106
2025-05-28	TAK	14.59	0.14	0.00	2139
2025-05-29	TAK	14.79	0.14	0.00	2143
2025-05-30	TAK	15.02	0.14	0.00	2171
2025-06-02	TAK	15.08	0.14	0.02	2172
2025-06-03	TAK	14.97	0.14	0.00	2217
2025-06-04	TAK	15.02	0.13	0.01	2238
2025-06-05	TAK	14.99	0.13	0.00	2279
2025-06-06	TAK	14.95	0.13	0.00	2279
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-05-07	TAK	15.06	-	703.3	0.00
2025-05-08	TAK	14.29	-	650.3	0.00
2025-05-09	TAK	14.36	-	731.8	0.00
2025-05-12	TAK	14.19	-	696.5	0.00
2025-05-13	TAK	13.72	-	723.0	0.00
2025-05-14	TAK	13.70	-	668.5	0.00
2025-05-15	TAK	14.00	-	723.4	0.00
2025-05-16	TAK	14.10	-	639.1	0.00
2025-05-19	TAK	14.23	-	646.3	0.00
2025-05-20	TAK	14.27	-	642.1	0.00
2025-05-21	TAK	14.32	-	975.9	0.00
2025-05-22	TAK	14.43	-	964.3	0.00
2025-05-23	TAK	14.56	-	980.0	0.00
2025-05-27	TAK	14.67	-	986.4	0.00
2025-05-28	TAK	14.59	-	958.1	0.00
2025-05-29	TAK	14.79	-	1085.8	0.00
2025-05-30	TAK	15.03	-	1105.3	0.00
2025-06-02	TAK	15.08	-	994.7	0.00
2025-06-03	TAK	14.97	-	997.8	0.00
2025-06-04	TAK	15.02	-	984.2	0.00
2025-06-05	TAK	14.99	-	983.0	0.00
2025-06-06	TAK	14.95	-	981.3	0.00
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-05-07	TAK	0.00	0.37	0.16
2025-05-08	TAK	0.00	0.37	0.16
2025-05-09	TAK	0.00	0.37	0.16
2025-05-12	TAK	0.00	0.37	0.15
2025-05-13	TAK	0.00	0.37	0.15
2025-05-14	TAK	0.00	0.37	0.15
2025-05-15	TAK	0.00	0.37	0.15
2025-05-16	TAK	0.00	0.37	0.15
2025-05-19	TAK	0.00	2.50	0.15
2025-05-20	TAK	0.00	2.50	0.15
2025-05-21	TAK	0.00	2.50	0.15
2025-05-22	TAK	0.00	2.50	0.15
2025-05-23	TAK	0.00	2.50	0.15
2025-05-27	TAK	0.00	2.41	0.15
2025-05-28	TAK	0.00	2.41	0.20
2025-05-29	TAK	0.00	2.41	0.20
2025-05-30	TAK	0.00	2.41	0.20
2025-06-02	TAK	0.00	2.37	0.20
2025-06-03	TAK	0.00	2.37	0.20
2025-06-04	TAK	0.00	2.37	0.20
2025-06-05	TAK	0.00	2.37	0.20
2025-06-06	TAK	0.00	2.37	0.20
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

2.37

Beta

0.26

Average Sales Estimate Current Quarter

1172160

Average Sales Estimate Next Quarter

1163330

Fair Value

18.07

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

25.3

Max Drawdown 5-Year %

-31.4

Target Price

17.27

P/E

68.84

Forward P/E

21.76

PEG

1.4

P/S

1.57

P/B

1.02

P/Free Cash Flow

9.45

EPS

0.22

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

2.35

Relative Volume

0.78

Return on Equity vs Sector %

-21.2

Return on Equity vs Industry %

-5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

981.3

Takeda Pharmaceutical Company L

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees:

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.

stock quote shares TAK – Takeda Pharmaceutical Company Limited Stock Price stock today

news today TAK – Takeda Pharmaceutical Company Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch TAK – Takeda Pharmaceutical Company Limited yahoo finance google finance

stock history TAK – Takeda Pharmaceutical Company Limited invest stock market

stock prices TAK premarket after hours

ticker TAK fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

TAK – Takeda Pharmaceutical Company Limited

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: TAK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y